AdvaMed® Cybersecurity Summit - AdvaMed® - Advanced Medical Technology Association®

Events AdvaMed® Cybersecurity Summit November 13, 2025 View more events Join AdvaMed® and industry experts to tackle evolving threats and FDA requirements in medtech cybersecurity. Overview Schedule Speakers Pricing Location AdvaMed® Cybersecurity Summit November 13, 2025 View more events Cyber threats are evolving as fast as medical technology. With increasing connectivity and advancing device capabilities, the risk to patients and health systems is greater than ever—and staying ahead of the curve is no longer optional. The 2025 Cybersecurity Summit in Washington, D.C. is designed around the issues keeping you up at night. You’ll hear from hospital CISOs about what they really need, share practical strategies with cyber peers from global companies, and prepare your 2026 cyber roadmap to better protect your organization. View the 2025 agenda! The 2025 Program Will Explore Global Trade & Supply Chain Security Impact of tariffs, export controls, and geopolitical tensions on medical device cybersecurity Ensuring component integrity and managing supply chain risk Hospital & Clinical Environment Security Real-world device security challenges in healthcare delivery organizations (HDOs) Collaboration between manufacturers and hospitals on vulnerabilities and incident response FDAs Shifting Cybersecurity Regulations Evolving FDA expectations for secure-by-design and total product lifecycle (TPLC) approaches Role of SBOMs, integration with Quality System Regulations, and considerations for AI/ML Privacy & Cybersecurity in Connected Health Intersection of HIPAA and cybersecurity in connected medical devices Managing data breach risks and regulatory compliance Vulnerability Disclosure & CISA Collaboration Coordinated vulnerability disclosure (CVD) processes Public-private partnerships and resources from CISA for threat mitigation Vulnerability scoring in practice and building robust postmarket cybersecurity programs that scale End-of-Life Cybersecurity Strategies Managing risks of EOL/EOS devices Best practices for policy development, communication, and secure device retirement Register Now Related Reading Event / Digital Health Expanding Service Margins While Protecting Clinical Availability March 26, 2026 11:30 AM – 12:30 PM Join Genpact as they help Medtech Service leaders tackle the margin challenge by transitioning to a Predictive Triage & Guaranteed Uptime model. Resource / Digital Health / Government & Legislative Affairs AdvaMed® 2025 Membership Has Its Privileges: Advocacy Wins for Medtech Members March 3, 2026 AdvaMed® 2025 Membership Has Its Privileges highlights major legislative and regulatory wins delivering millions in savings and new revenue for members. Resource / Artificial Intelligence (AI) / Coverage & Payment / Digital Health / Regulatory Affairs AdvaMed® Comment Letter to ASTP/ONC: Accelerating AI Adoption in Clinical Care February 24, 2026 AdvaMed’s® Comment Letter to ASTP/ONC, outlines concrete policy reforms across FDA oversight, CMS payment pathways, and HIPAA data-sharing rules to accelerate patient access to AI-enabled medical technologies. As AI-enabled medical devices transform patient care, outdated regulatory, coverage, and privacy frameworks are slowing the pace of adoption. News / Artificial Intelligence (AI) / Regulatory Affairs i-GENTIC AI Launches Context-Aware MedTech Agents to Strengthen FDA 510(k) Submission Consistency February 23, 2026 PALO ALTO, Calif., Feb. 11, 2026 i-GENTIC AI today announced a new suite of context-aware, multilingual MedTech agents designed to help medical device manufacturers improve the quality and consistency of FDA 510(k) submissions. Preparing a 510(k) often takes months, yet many submissions require additional information requests or are rejected due to inconsistencies across documents, evidence, and claims, creating delays and added costs for manufacturers. News / Diabetes / Digital Health Dexcom’s Jake Leach Named Chair of AdvaMed’s Diabetes Sector February 23, 2026 WASHINGTON—AdvaMed, the MedTech Association®, today announced that Jacob “Jake” Leach, President and Chief Executive Officer at Dexcom, will serve as the next chair of theAdvaMed® Diabetes Sector, succeeding Chris Scoggins, Executive Vice President of Diabetes Care at Abbott. TheAdvaMed® Diabetes Sector represents the world’s leading companies producing technology across the spectrum of diabetes care.  Blog / Regulatory Affairs Why Practical FDA Submissions Training Makes the Difference February 17, 2026 Explore AdvaMed’s Medical Device Submissions Workshop Series from practical submission strategies to live expert insights you can apply immediately. Blog / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access Heart Month: Why Sleep Apnea Belongs at the Center of Cardiovascular Care February 13, 2026 February is American Heart Month—a time to spotlight cardiovascular disease and highlight innovations that can improve patient outcomes. For the medtech community, it’s an opportunity to address persistent gaps in care through technology, data, collaboration, and policy advancement. Despite progress in treating heart conditions, sleep disorders—especially sleep apnea—remain a significant and underrecognized contributor to poor cardiovascular outcomes.1 Tackling this issue requires clinical awareness and supportive policies for timely diagnosis, coverage, and care beyond traditional settings. News / Coverage & Payment / Diagnostics / Regulatory Affairs AdvaMed® Announces Melissa Torres as New Executive Vice President of Technology and Regulatory Affairs   February 10, 2026 WASHINGTON—AdvaMed, the MedTech Association®, today announced Melissa Torres is the new Executive Vice President of Technology and Regulatory Affairs. Torres succeeds Janet Trunzo, who retired after 30 distinguished, productive years withAdvaMed®.  Hear From Us Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community. Subscribe